Atazanavir/r approved in Europefor children aged 6 to 18 years

On 7 July 2010, the use of boosted atazanavir was extended in Europe to include children aged 6–18 years old, weighing >15kg. [1]

This was based on results from the open label multicentre PACTG 1020A study. [2]

The study included 182 naive and experienced paediatric patients aged 6 to 18 years old, using once daily atazanavir, with (n=141) or without (n=41) ritonavir, in combination with two NRTIs. The data from the 41 patients using ritonavir-boosting (n=16 naive and 25) supported this new paediatric indication.

The recommended atazanavir/ritonavir doses by body weight are 150 mg/100 mg (15kg–less than 20 kg) and 200 mg/100 mg (20 kg–less than 40 kg); with children weighing over 40 kg recommended to use the standard adult dose of 300 mg/100 mg.

Source: BMS press release (07 July 2010).

Links to other websites are current at date of posting but not maintained.